Summary
The video covers the opening bell for the NYSE and Nasdaq on January 22, 2026, including BitGo's IPO celebration and Medicus Pharma's one-year listing anniversary. Jim Cramer discusses a jarring decline in a big-cap pharma name (Abbott) and whether it is a buying opportunity. He also talks about capital rotation from high-flying memory names like Micron and SanDisk back into traditional tech. The segment ends with Cramer noting that traditional tech names need capital, catalysts, or turnarounds.
- Opening bell coverage for NYSE and Nasdaq on January 22, 2026.
- BitGo celebrates its IPO at the NYSE; Medicus Pharma marks one-year listing anniversary at Nasdaq.
- Jim Cramer considers whether a jarring decline in a big-cap pharma name is a buying opportunity.
- Cramer calls Micron and SanDisk 'destroyers' that have absorbed large amounts of capital.
- Cramer expects money to rotate from memory names back into traditional tech.
- Cramer mentions Alphabet, Apple, Amazon, Meta, and Microsoft as traditional tech names needing capital or turnarounds.